Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer
出版年份 2011 全文链接
标题
Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer
作者
关键词
-
出版物
Future Medicinal Chemistry
Volume 4, Issue 1, Pages 107-119
出版商
Future Science, LTD
发表日期
2011-12-15
DOI
10.4155/fmc.11.161
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cabozantinib (XL184) in metastatic castration-resistant prostate cancer (mCRPC): Results from a phase II randomized discontinuation trial.
- (2017) M. Hussain et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Markers and Death From Prostate Cancer
- (2013) John Concato ANNALS OF INTERNAL MEDICINE
- Fibroblast growth factors and their receptors in cancer
- (2011) Jørgen Wesche et al. BIOCHEMICAL JOURNAL
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
- (2011) Brett S. Carver et al. CANCER CELL
- Fyn Is Downstream of the HGF/MET Signaling Axis and Affects Cellular Shape and Tropism in PC3 Cells
- (2011) A. R. Jensen et al. CLINICAL CANCER RESEARCH
- Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3
- (2011) L. Chen et al. CLINICAL CANCER RESEARCH
- Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies
- (2011) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatocyte growth factor twenty years on: Much more than a growth factor
- (2011) Takahiro Nakamura et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Correction: Bone metastasis in prostate cancer: emerging therapeutic strategies
- (2011) Justin Sturge et al. Nature Reviews Clinical Oncology
- Early Clinical Development of ARQ 197, a Selective, Non-ATP-Competitive Inhibitor Targeting MET Tyrosine Kinase for the Treatment of Advanced Cancers
- (2011) A. A. Adjei et al. ONCOLOGIST
- Differential transformation capacity of Src family kinases during the initiation of prostate cancer
- (2011) H. Cai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Once-daily Dasatinib: Expansion of Phase II Study Evaluating Safety and Efficacy of Dasatinib in Patients With Metastatic Castration-resistant Prostate Cancer
- (2011) Evan Y. Yu et al. UROLOGY
- A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer
- (2010) Srikala S. Sridhar et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Defining the pathway to insulin-like growth factor system targeting in cancer
- (2010) Steven A. Rosenzweig et al. BIOCHEMICAL PHARMACOLOGY
- A pilot dose-escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancer
- (2010) Charles J. Ryan et al. BJU INTERNATIONAL
- Efficacy of c-Met inhibitor for advanced prostate cancer
- (2010) William H Tu et al. BMC CANCER
- Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells
- (2010) L. Chen et al. CANCER RESEARCH
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Paths of FGFR-driven tumorigenesis
- (2010) Victor D. Acevedo et al. CELL CYCLE
- A Phase I Study of Foretinib, a Multi-Targeted Inhibitor of c-Met and Vascular Endothelial Growth Factor Receptor 2
- (2010) J. P. Eder et al. CLINICAL CANCER RESEARCH
- AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer
- (2010) D. M. Hickinson et al. CLINICAL CANCER RESEARCH
- Shepherding AKT and androgen receptor by Ack1 tyrosine kinase
- (2010) Kiran Mahajan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer
- (2010) Robert G. Maki JOURNAL OF CLINICAL ONCOLOGY
- BMS-777607, a Small-Molecule Met Kinase Inhibitor, Suppresses Hepatocyte Growth Factor-Stimulated Prostate Cancer Metastatic Phenotype In vitro
- (2010) Y. Dai et al. MOLECULAR CANCER THERAPEUTICS
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts
- (2010) Y-C Lee et al. ONCOGENE
- Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases
- (2010) Y Liu et al. ONCOGENE
- Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy
- (2009) G. Sonpavde et al. ANNALS OF ONCOLOGY
- Phase II study of sunitinib in men with advanced prostate cancer
- (2009) M. Dror Michaelson et al. ANNALS OF ONCOLOGY
- A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study
- (2009) Primo N. Lara et al. ANTI-CANCER DRUGS
- Signal co-operation between integrins and other receptor systems
- (2009) Charles H. Streuli et al. BIOCHEMICAL JOURNAL
- Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer
- (2009) Jeanny B. Aragon-Ching et al. BJU INTERNATIONAL
- MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer
- (2009) Wenqing Qi et al. BMC CANCER
- Epidermal growth factor signalling and bone metastasis
- (2009) X Lu et al. BRITISH JOURNAL OF CANCER
- Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases
- (2009) F. Qian et al. CANCER RESEARCH
- Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
- (2009) E. Y. Yu et al. CLINICAL CANCER RESEARCH
- Targeting of Bone-Derived Insulin-Like Growth Factor-II by a Human Neutralizing Antibody Suppresses the Growth of Prostate Cancer Cells in a Human Bone Environment
- (2009) T. Kimura et al. CLINICAL CANCER RESEARCH
- Urine Analysis and Protein Networking Identify Met as a Marker of Metastatic Prostate Cancer
- (2009) A. L. Russo et al. CLINICAL CANCER RESEARCH
- PDGF-D Signaling: A Novel Target in Cancer Therapy
- (2009) Zhiwei Wang et al. CURRENT DRUG TARGETS
- HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells
- (2009) Marta Soler et al. INTERNATIONAL JOURNAL OF CANCER
- Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial
- (2009) Rosemary A Hannon et al. JOURNAL OF BONE AND MINERAL RESEARCH
- BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
- (2009) J. M. Carboni et al. MOLECULAR CANCER THERAPEUTICS
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- De-regulated FGF receptors as therapeutic targets in cancer
- (2009) Victoria Knights et al. PHARMACOLOGY & THERAPEUTICS
- Mammalian Target of Rapamycin Repression by 3,3'-Diindolylmethane Inhibits Invasion and Angiogenesis in Platelet-Derived Growth Factor-D-Overexpressing PC3 Cells
- (2008) D. Kong et al. CANCER RESEARCH
- Suppression of Prostate Cancer Nodal and Systemic Metastasis by Blockade of the Lymphangiogenic Axis
- (2008) J. B. Burton et al. CANCER RESEARCH
- Targeting Src Family Kinases Inhibits Growth and Lymph Node Metastases of Prostate Cancer in an Orthotopic Nude Mouse Model
- (2008) S. I. Park et al. CANCER RESEARCH
- Understanding the Biology of Bone Metastases: Key to the Effective Treatment of Prostate Cancer
- (2008) C. J. Logothetis et al. CLINICAL CANCER RESEARCH
- Targeting the c-MET signaling pathway for cancer therapy
- (2008) Xiangdong Liu et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells
- (2008) Hewang Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Neoadjuvant Platelet Derived Growth Factor Receptor Inhibitor Therapy Combined With Docetaxel and Androgen Ablation for High Risk Localized Prostate Cancer
- (2008) Paul Mathew et al. JOURNAL OF UROLOGY
- Unknown
- (2008) Efstathia Papageorgiou et al. MOLECULAR MEDICINE
- Cancer as an overhealing wound: an old hypothesis revisited
- (2008) Matthias Schäfer et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer
- (2008) Kenji Yasuda et al. PROSTATE
- Platelet-Derived Growth Factor-D Overexpression Contributes to Epithelial-Mesenchymal Transition of PC3 Prostate Cancer Cells
- (2008) Dejuan Kong et al. STEM CELLS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started